Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 169

1.
2.
3.

Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications.

Craft S.

Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):298-301. Review.

PMID:
17132977
4.

Insulin resistance and Alzheimer's disease: molecular links & clinical implications.

Neumann KF, Rojo L, Navarrete LP, Farías G, Reyes P, Maccioni RB.

Curr Alzheimer Res. 2008 Oct;5(5):438-47.

PMID:
18855585
5.
6.

Insulin resistance, inflammation, and cognition in Alzheimer's Disease: lessons for multiple sclerosis.

Watson GS, Craft S.

J Neurol Sci. 2006 Jun 15;245(1-2):21-33. Epub 2006 Apr 24. Review.

PMID:
16631207
7.

Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

Biessels GJ, Kappelle LJ; Utrecht Diabetic Encephalopathy Study Group.

Biochem Soc Trans. 2005 Nov;33(Pt 5):1041-4. Review.

PMID:
16246041
8.
9.

Modulation of memory by insulin and glucose: neuropsychological observations in Alzheimer's disease.

Watson GS, Craft S.

Eur J Pharmacol. 2004 Apr 19;490(1-3):97-113. Review.

PMID:
15094077
12.

Differential modulation of plasma beta-amyloid by insulin in patients with Alzheimer disease.

Kulstad JJ, Green PS, Cook DG, Watson GS, Reger MA, Baker LD, Plymate SR, Asthana S, Rhoads K, Mehta PD, Craft S.

Neurology. 2006 May 23;66(10):1506-10.

PMID:
16717209
13.

Insulin receptor mutation results in insulin resistance and hyperinsulinemia but does not exacerbate Alzheimer's-like phenotypes in mice.

Murakami K, Yokoyama S, Murata N, Ozawa Y, Irie K, Shirasawa T, Shimizu T.

Biochem Biophys Res Commun. 2011 May 27;409(1):34-9. doi: 10.1016/j.bbrc.2011.04.101. Epub 2011 Apr 28.

PMID:
21549686
14.

The role of gonadotropins in Alzheimer's disease: potential neurodegenerative mechanisms.

Barron AM, Verdile G, Martins RN.

Endocrine. 2006 Apr;29(2):257-69. Review.

PMID:
16785601
15.
16.

Beta-amyloid pathology in the entorhinal cortex of rats induces memory deficits: implications for Alzheimer's disease.

Sipos E, Kurunczi A, Kasza A, Horváth J, Felszeghy K, Laroche S, Toldi J, Párducz A, Penke B, Penke Z.

Neuroscience. 2007 Jun 15;147(1):28-36. Epub 2007 May 17.

PMID:
17499931
17.

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

Salkovic-Petrisic M, Hoyer S.

J Neural Transm Suppl. 2007;(72):217-33. Review.

PMID:
17982898
18.

Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.

de la Monte SM.

Drugs. 2012 Jan 1;72(1):49-66. doi: 10.2165/11597760-000000000-00000. Review.

19.

Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: relevance to Alzheimer's disease.

de la Monte SM, Tong M, Lester-Coll N, Plater M Jr, Wands JR.

J Alzheimers Dis. 2006 Sep;10(1):89-109. Review.

PMID:
16988486
20.

Does insulin dysfunction play a role in Alzheimer's disease?

Gasparini L, Netzer WJ, Greengard P, Xu H.

Trends Pharmacol Sci. 2002 Jun;23(6):288-93. Review.

PMID:
12084635

Supplemental Content

Support Center